Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.02
THC's Cash to Debt is ranked lower than
55% of the 350 Companies
in the Global Medical Care industry.

( Industry Median: 0.20 vs. THC: 0.02 )
THC' s 10-Year Cash to Debt Range
Min: 0   Max: 0.29
Current: 0.02

0
0.29
Equity to Asset 0.04
THC's Equity to Asset is ranked lower than
53% of the 334 Companies
in the Global Medical Care industry.

( Industry Median: 0.42 vs. THC: 0.04 )
THC' s 10-Year Equity to Asset Range
Min: 0.01   Max: 0.41
Current: 0.04

0.01
0.41
Interest Coverage 1.23
THC's Interest Coverage is ranked lower than
53% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 6.13 vs. THC: 1.23 )
THC' s 10-Year Interest Coverage Range
Min: 0.62   Max: 6.4
Current: 1.23

0.62
6.4
F-Score: 7
Z-Score: 1.24
WACC vs ROIC
6.77%
37.52%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 5.46
THC's Operating margin (%) is ranked higher than
66% of the 350 Companies
in the Global Medical Care industry.

( Industry Median: 9.21 vs. THC: 5.46 )
THC' s 10-Year Operating margin (%) Range
Min: -14.26   Max: 15.05
Current: 5.46

-14.26
15.05
Net-margin (%) 0.07
THC's Net-margin (%) is ranked higher than
58% of the 350 Companies
in the Global Medical Care industry.

( Industry Median: 4.59 vs. THC: 0.07 )
THC' s 10-Year Net-margin (%) Range
Min: -32   Max: 13.5
Current: 0.07

-32
13.5
ROE (%) 1.67
THC's ROE (%) is ranked higher than
58% of the 331 Companies
in the Global Medical Care industry.

( Industry Median: 11.00 vs. THC: 1.67 )
THC' s 10-Year ROE (%) Range
Min: -124.98   Max: 94.78
Current: 1.67

-124.98
94.78
ROA (%) 0.07
THC's ROA (%) is ranked higher than
59% of the 356 Companies
in the Global Medical Care industry.

( Industry Median: 4.18 vs. THC: 0.07 )
THC' s 10-Year ROA (%) Range
Min: -25.08   Max: 13.89
Current: 0.07

-25.08
13.89
ROC (Joel Greenblatt) (%) 10.66
THC's ROC (Joel Greenblatt) (%) is ranked higher than
66% of the 353 Companies
in the Global Medical Care industry.

( Industry Median: 17.58 vs. THC: 10.66 )
THC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -19.75   Max: 34.13
Current: 10.66

-19.75
34.13
Revenue Growth (3Y)(%) 32.40
THC's Revenue Growth (3Y)(%) is ranked higher than
97% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. THC: 32.40 )
THC' s 10-Year Revenue Growth (3Y)(%) Range
Min: -13.7   Max: 34.9
Current: 32.4

-13.7
34.9
EBITDA Growth (3Y)(%) 31.20
THC's EBITDA Growth (3Y)(%) is ranked higher than
96% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. THC: 31.20 )
THC' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -47.2   Max: 31.5
Current: 31.2

-47.2
31.5
EPS Growth (3Y)(%) -15.30
THC's EPS Growth (3Y)(%) is ranked higher than
56% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. THC: -15.30 )
THC' s 10-Year EPS Growth (3Y)(%) Range
Min: -69.8   Max: 57
Current: -15.3

-69.8
57
» THC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

THC Guru Trades in Q1 2014

Louis Moore Bacon 8,988 sh (New)
Mario Gabelli 15,000 sh (New)
Manning & Napier Advisors, Inc 220,380 sh (New)
Steven Cohen 21,789 sh (+56.61%)
Ray Dalio 33,400 sh (+53.71%)
Vanguard Health Care Fund 1,400,000 sh (unchged)
Larry Robbins 13,812,831 sh (unchged)
Jim Simons Sold Out
Jeremy Grantham Sold Out
Paul Tudor Jones Sold Out
» More
Q2 2014

THC Guru Trades in Q2 2014

George Soros 22,150 sh (New)
Louis Moore Bacon 154,841 sh (+1622.75%)
Larry Robbins 13,812,831 sh (unchged)
Mario Gabelli 15,000 sh (unchged)
Vanguard Health Care Fund 1,400,000 sh (unchged)
Manning & Napier Advisors, Inc 220,380 sh (unchged)
Ray Dalio 14,725 sh (-55.91%)
» More
Q3 2014

THC Guru Trades in Q3 2014

Jim Simons 68,475 sh (New)
Ken Heebner 1,965,000 sh (New)
Louis Moore Bacon 162,451 sh (+4.91%)
Vanguard Health Care Fund 1,460,000 sh (+4.29%)
Larry Robbins 13,812,831 sh (unchged)
George Soros Sold Out
Ray Dalio Sold Out
Manning & Napier Advisors, Inc 187,190 sh (-15.06%)
Mario Gabelli 10,000 sh (-33.33%)
» More
Q4 2014

THC Guru Trades in Q4 2014

Steven Cohen 54,500 sh (New)
Paul Tudor Jones 8,903 sh (New)
Jim Simons 339,175 sh (+395.33%)
Mario Gabelli 15,000 sh (+50.00%)
Vanguard Health Care Fund 1,460,000 sh (unchged)
Larry Robbins 13,812,831 sh (unchged)
Manning & Napier Advisors, Inc Sold Out
Ken Heebner Sold Out
Louis Moore Bacon 21,999 sh (-86.46%)
» More
» Details

Insider Trades

Latest Guru Trades with THC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 955.50
THC's P/E(ttm) is ranked higher than
60% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 54.70 vs. THC: 955.50 )
THC' s 10-Year P/E(ttm) Range
Min: 1.87   Max: 978.3
Current: 955.5

1.87
978.3
Forward P/E 19.72
THC's Forward P/E is ranked higher than
84% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. THC: 19.72 )
N/A
PE(NRI) 190.60
THC's PE(NRI) is ranked higher than
68% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 52.30 vs. THC: 190.60 )
THC' s 10-Year PE(NRI) Range
Min: 1.51   Max: 1296
Current: 190.6

1.51
1296
P/B 7.50
THC's P/B is ranked lower than
54% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 3.80 vs. THC: 7.50 )
THC' s 10-Year P/B Range
Min: 1.2   Max: 101.5
Current: 7.5

1.2
101.5
P/S 0.30
THC's P/S is ranked higher than
95% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 2.00 vs. THC: 0.30 )
THC' s 10-Year P/S Range
Min: 0.05   Max: 0.72
Current: 0.3

0.05
0.72
POCF 7.65
THC's POCF is ranked higher than
89% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 22.00 vs. THC: 7.65 )
THC' s 10-Year POCF Range
Min: 1.31   Max: 22.8
Current: 7.65

1.31
22.8
EV-to-EBIT 18.18
THC's EV-to-EBIT is ranked higher than
83% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 31.13 vs. THC: 18.18 )
THC' s 10-Year EV-to-EBIT Range
Min: -2497.3   Max: 31.8
Current: 18.18

-2497.3
31.8
PEG 13.61
THC's PEG is ranked higher than
85% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. THC: 13.61 )
THC' s 10-Year PEG Range
Min: 2.78   Max: 31.32
Current: 13.61

2.78
31.32
Shiller P/E 28.10
THC's Shiller P/E is ranked higher than
88% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. THC: 28.10 )
THC' s 10-Year Shiller P/E Range
Min: 15.35   Max: 692
Current: 28.1

15.35
692
Current Ratio 1.32
THC's Current Ratio is ranked higher than
70% of the 337 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. THC: 1.32 )
THC' s 10-Year Current Ratio Range
Min: 1.19   Max: 1.96
Current: 1.32

1.19
1.96
Quick Ratio 1.24
THC's Quick Ratio is ranked higher than
71% of the 337 Companies
in the Global Medical Care industry.

( Industry Median: 1.12 vs. THC: 1.24 )
THC' s 10-Year Quick Ratio Range
Min: 1.11   Max: 1.85
Current: 1.24

1.11
1.85
Days Inventory 8.85
THC's Days Inventory is ranked higher than
91% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 42.57 vs. THC: 8.85 )
THC' s 10-Year Days Inventory Range
Min: 8.22   Max: 21.55
Current: 8.85

8.22
21.55
Days Sales Outstanding 50.15
THC's Days Sales Outstanding is ranked higher than
72% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 54.36 vs. THC: 50.15 )
THC' s 10-Year Days Sales Outstanding Range
Min: 46.89   Max: 87.69
Current: 50.15

46.89
87.69

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.90
THC's Price/Median PS Value is ranked higher than
92% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 1.40 vs. THC: 0.90 )
THC' s 10-Year Price/Median PS Value Range
Min: 0.18   Max: 5.13
Current: 0.9

0.18
5.13
Price/Peter Lynch Fair Value 12.00
THC's Price/Peter Lynch Fair Value is ranked higher than
85% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. THC: 12.00 )
THC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.39   Max: 12.01
Current: 12

1.39
12.01
Earnings Yield (Greenblatt) 5.50
THC's Earnings Yield (Greenblatt) is ranked higher than
78% of the 345 Companies
in the Global Medical Care industry.

( Industry Median: 4.30 vs. THC: 5.50 )
THC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.1   Max: 10.6
Current: 5.5

3.1
10.6
Forward Rate of Return (Yacktman) 14.72
THC's Forward Rate of Return (Yacktman) is ranked higher than
81% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 11.83 vs. THC: 14.72 )
THC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -103.1   Max: 14.8
Current: 14.72

-103.1
14.8

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:THC1.Germany,
Tenet Healthcare Corp, a Nevada corporation was incorporated in 1975. It is an investor-owned company whose subsidiaries and affiliates operate regionally focused, integrated health care delivery networks with a significant presence in several large urban and suburban markets. At the core of its networks are acute care and specialty hospitals that, together with its strategically aligned outpatient facilities and related businesses, allow them to provide a comprehensive range of health care services in the communities they serve. The Company primarily operated 77 hospitals, 183 outpatient centers, six health plans, six accountable care networks and Conifer Health Solutions, LLC ("Conifer"), which provides business process solutions to more than 700 hospital and other clients nationwide. It provides comprehensive operational management for revenue cycle functions, including patient access, health information management, revenue integrity and patient financial services. They also offer communications and engagement solutions to optimize the relationship between providers and patients. In addition, its management services offerings have expanded to support value-based performance through clinical integration, financial risk management and population health management. For financial reporting purposes, its business lines are classified into two separate reportable business segments — hospital operations and other, and Conifer. Its subsidiaries operated 77 hospitals, including four academic medical centers, two children's hospitals, three specialty hospitals and a critical access hospital, with a total of 20,293 licensed beds, serving primarily urban and suburban communities in 14 states. Of those hospitals, 72 were owned by its subsidiaries, and five were owned by third parties and leased by its subsidiaries. They are also in the process of constructing the new Resolute Health Hospital and Wellness Campus in New Braunfels, Texas, which is expected to be completed in or around May 2014. In addition, its subsidiaries operated a long-term acute care hospital and owned or leased and operated a number of medical office buildings, all of which were located on, or nearby, its hospital campuses. Furthermore, its subsidiaries operated 183 free-standing and provider-based outpatient centers in 16 states including diagnostic imaging centers, ambulatory surgery centers, urgent care centers and satellite emergency departments, among others. They also owned over 500 physician practices. Many of its hospitals also offer a wide range of clinical research studies, giving patients access to innovative care. The Company also own or control six accountable care networks — in Florida, California, Illinois, Michigan and Texas — and participate in two additional accountable care networks through collaborations with other health care providers in its markets in Arizona and Massachusetts. These networks operate using a range of payment and delivery mod
» More Articles for NYSE:THC

Headlines

Articles On GuruFocus.com
Humana And Concentra To Part Ways Mar 27 2015 
Tenet Healthcare And United Surgical JV For $1.93 Billion Mar 24 2015 
Mario Gabelli’s Equity Income Fund Q3 2014 Commentary Oct 29 2014 
Time to Buy Tenet Healthcare? Aug 22 2014 
ObamaCare A Boon For Hostpitals Aug 19 2014 
A Far-Larger Hospital and a Far-Larger Stock Position Jan 02 2014 
Gabelli and Robbins Highlight Guru Buys of the Week Dec 27 2013 
Larry Robbins Ups Holdings in Health Care Company Dec 24 2013 
Robbins, Cohen and Karr Highlight the Guru Real Time Picks of the Week Dec 20 2013 
Glenview Capital - Larry Robbins in Real Time and Review Nov 15 2013 


More From Other Websites
HCA Holdings: What to Expect from 1Q15 May Earnings Release Apr 23 2015
Tenet Announces Hospital Leadership Appointments Apr 21 2015
Tenet Announces Hospital Leadership Appointments Apr 21 2015
Editor's take: Exxon's $33M CEO, inside the biggest store in Texas and why it pays to be an... Apr 19 2015
Hospital operator HCA Holdings' preliminary results beat estimates Apr 15 2015
Jeb Bush delivers stump speech on Kasich’s home turf Apr 14 2015
Traders turning cautious on Tenet Apr 14 2015
Lone Pine Initiates New Position in HCA Holdings Apr 14 2015
Notable option activity in equities Apr 13 2015
Best Real Estate Deals of the Year: Your guide to the 2015 winners Apr 10 2015
Deal makers, movers, shakers celebrate Best Real Estate Deals of 2014 Apr 09 2015
Health Net Subsidiary Improves Care Access for Veterans - Analyst Blog Apr 08 2015
Thermo Fisher Scientific Inc. (TMO), Monsanto Company (MON): Billionaire Larry Robbins’ Top Picks... Apr 08 2015
Tenet to Report First Quarter Results on May 4, 2015 Apr 06 2015
Tenet to Report First Quarter Results on May 4, 2015 Apr 06 2015
These 10 Pharma and Health Care Stocks Were the Worst S&P 500 Performers Last Quarter Apr 02 2015
Traders bet on recovery in Tenet Apr 02 2015
Baylor Scott & White Health and Tenet to Partner on Five North Texas Hospitals Apr 02 2015
The Week in Review: RadioShack, American, Toyota steal the headlines Mar 29 2015
Tenet Said to Talk With Lenders on $2 Billion Loan for USPI Deal Mar 26 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK